Brightlands Venture Partners joins Healthplus.ai seed extension, taking round to EUR 3.3 million

• Healthplus.ai raised a seed round extension led by Brightlands Venture Partners, funding rollout of its CE-certified PERISCOPE surgical infection-risk platform.
• PERISCOPE uses hospital data to predict postoperative infection risk up to 30 days post-surgery, integrating into clinical workflows without new data entry.
• Total seed financing reached EUR 3.3 million, supporting expansion across European hospitals and development for additional surgical complications.
• Proceeds also fund a multi-center clinical trial to support an FDA approval pathway in the U.S.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Brightlands Venture Partners BV published the original content used to generate this news brief on September 03, 2026, and is solely responsible for the information contained therein.